Cargando…

Fibrinolytic assays in bleeding of unknown cause: Improvement in diagnostic yield

INTRODUCTION: Analysis of fibrinolytic disorders is challenging and may potentially lead to underdiagnosis of patients with an increased bleeding tendency. AIM: To compare clinical characteristics, laboratory measurements, and treatment modalities in a monocenter cohort of patients in whom fibrinoly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valke, Lars L. F. G., Meijer, Danielle, Nieuwenhuizen, Laurens, Laros‐van Gorkom, Britta A. P., Blijlevens, Nicole M. A., van Heerde, Waander L., Schols, Saskia E. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922970/ https://www.ncbi.nlm.nih.gov/pubmed/35316940 http://dx.doi.org/10.1002/rth2.12681

Ejemplares similares

Thrombin generation assays to personalize treatment in bleeding and thrombotic diseases
por: Valke, Lars L. F. G., et al.
Publicado: (2022)

Pharmacodynamic monitoring of factor VIII replacement therapy in hemophilia A: Combining thrombin and plasmin generation
por: Valke, Lars L.F.G., et al.
Publicado: (2020)

Combining factor VIII levels and thrombin/plasmin generation: A population pharmacokinetic‐pharmacodynamic model for patients with haemophilia A
por: Bukkems, Laura H., et al.
Publicado: (2022)

Von Willebrand disease type 2M: Correlation between genotype and phenotype
por: Maas, Dominique P. M. S. M., et al.
Publicado: (2021)

Acquired von Willebrand Disease Associated with Mantle Cell Lymphoma
por: Maas, Dominique, et al.
Publicado: (2018)

Treatment of patients with rare bleeding disorders in the Netherlands: Real‐life data from the RBiN study
por: Maas, Dominique P. M. S. M., et al.
Publicado: (2022)

Diagnostic work up of patients with increased bleeding tendency
por: Zegers, Suzanne A. M., et al.
Publicado: (2019)

In patients with hemophilia, a decreased thrombin generation profile is associated with a severe bleeding phenotype
por: Verhagen, Marieke J.A., et al.
Publicado: (2023)

Pregnancy outcome in afibrinogenemia: Are we giving enough fibrinogen concentrate? A case series
por: Saes, Joline L., et al.
Publicado: (2020)

Importance of Genotyping in von Willebrand Disease to Elucidate Pathogenic Mechanisms and Variability in Phenotype
por: Atiq, Ferdows, et al.
Publicado: (2022)

Major differences in clinical presentation, diagnosis and management of men and women with autosomal inherited bleeding disorders
por: Atiq, F., et al.
Publicado: (2021)

Thrombin and plasmin generation in patients with plasminogen or plasminogen activator inhibitor type 1 deficiency
por: Saes, Joline L., et al.
Publicado: (2019)

ADAMTS‐13 and bleeding phenotype in von Willebrand disease
por: Boender, Johan, et al.
Publicado: (2020)

BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease
por: Atiq, Ferdows, et al.
Publicado: (2019)

Dosing of factor VIII concentrate by ideal body weight is more accurate in overweight and obese haemophilia A patients
por: van Moort, Iris, et al.
Publicado: (2020)

The bleeding phenotype in people with nonsevere hemophilia
por: Kloosterman, Fabienne R., et al.
Publicado: (2022)

Thrombin generation for monitoring hemostatic therapy in hemophilia A: A narrative review
por: Verhagen, Marieke J. A., et al.
Publicado: (2022)

Sports participation and physical activity in patients with von Willebrand disease
por: Atiq, Ferdows, et al.
Publicado: (2018)

Long-term impact of joint bleeds in von Willebrand disease: a nested case-control study
por: van Galen, Karin P.M., et al.
Publicado: (2017)

Assessing plasminogen activation potential with global fibrinolytic assays
por: Urano, Tetsumei, et al.
Publicado: (2019)

Luminescent Assay for the Screening of SARS‐CoV‐2 M(Pro) Inhibitors
por: Sondag, Daan, et al.
Publicado: (2022)

Fibrinolytic Changes in Women with Preeclampsia
por: Godtfredsen, Anne Cathrine, et al.
Publicado: (2022)

Molecular mechanisms of bleeding disorderassociated GFI1B(Q287*) mutation and its affected pathways in megakaryocytes and platelets
por: van Oorschot, Rinske, et al.
Publicado: (2019)

Improved neurocognitive functions correlate with reduced inflammatory burden in atrial fibrillation patients treated with intensive cholesterol lowering therapy
por: Lappegård, Knut Tore, et al.
Publicado: (2013)

Clinical effects of tranexamic acid on bleeding tendency due to fibrinolytic activation of AL amyloidosis
por: Matsumoto, Gaku, et al.
Publicado: (2023)

Fibrinolysis and bleeding of unknown cause
por: Mehic, Dino, et al.
Publicado: (2021)

THE FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI
por: Tillett, William S., et al.
Publicado: (1933)

The Fibrinolytic System: Mysteries and Opportunities
por: Medcalf, Robert L., et al.
Publicado: (2021)

The SLIM study—Shared medical appointments to change lifestyles of overweight people with haemophilia: A randomized multiple baseline (n‐of‐1) design
por: Hendriks, Marcel A. L., et al.
Publicado: (2021)

Desmopressin treatment combined with clotting factor VIII concentrates in patients with non-severe haemophilia A: protocol for a multicentre single-armed trial, the DAVID study
por: Schütte, Lisette M, et al.
Publicado: (2019)

Polymorphisms on PAI-1 and ACE genes in association with fibrinolytic bleeding after on-pump cardiac surgery
por: Ozolina, Agnese, et al.
Publicado: (2015)

Laboratory evaluation of a new integrative assay to phenotype plasma fibrinolytic system
por: Bareille, Marion, et al.
Publicado: (2022)

Platelet CD34 expression in a patient with a partial deletion of transcription factor subunit CBFB
por: van Bergen, Maaike G.J.M., et al.
Publicado: (2020)

Bleeding Risk With Combination Intrapleural Fibrinolytic and Enzyme Therapy in Pleural Infection: An International, Multicenter, Retrospective Cohort Study
por: Akulian, Jason, et al.
Publicado: (2022)

Desmopressin response depends on the presence and type of genetic variants in patients with type 1 and type 2 von Willebrand disease
por: Atiq, Ferdows, et al.
Publicado: (2022)

Fibrinolytic Therapy in Acute Stroke
por: Millán, Mònica, et al.
Publicado: (2010)

Therapeutics targeting the fibrinolytic system
por: Lin, Haili, et al.
Publicado: (2020)

Fibrinolytics and Intraventricular Hemorrhage: A Systematic Review and Meta-analysis
por: van Solinge, Thomas S., et al.
Publicado: (2019)

PGM Guidelines for Description of Criteria and Methods for Testing of Specificity of Assay Methods for Quantities in the Fibrinolytic System
por: Gram, Jørgen, et al.
Publicado: (2000)

SYMPHONY consortium: Orchestrating personalized treatment for patients with bleeding disorders
por: Cnossen, Marjon H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1qdpvg58lptt4oahb3sagskifq